Back
Open Access

Very low dose of rivaroxaban. It is time for a new era.

Session: Welcome and Session 1: From ACS to chronic coronary artery disease. The transition period
Topic: Thrombosis, Bleeding
Speaker: Professor J. Morais (Leiria, PT)
Event: Hot topics and new insights for Thrombosis 2022

Seminar Presentation

About the speaker

Professor Joao Morais

Leiria Hospital Centre, Leiria (Portugal)
18 presentations
0 follower

4 more presentations in this session

Welcome & Introduction .

Speaker: Doctor G. Vilahur (Barcelona, ES)

Access
Video
Thumbnail

Dual anti platelet therapy duration? Very short or very long?

Speaker: Professor J. ten Berg (Nieuwegein, NL)

Access
Video
Thumbnail

De-escalation of monotherapy with P2Y12 inhibitor. An alternative approach.

Speaker: Doctor J. Ferreiro (Tarragona, ES)

Access
Video
Thumbnail

The bleeding risk the true game changer.

Speaker: Professor T. Geisler (Tuebingen, DE)

Access
Video
Thumbnail

Access the full session

Welcome and Session 1: From ACS to chronic coronary artery disease. The transition period

Speakers: Professor J. Morais, Doctor G. Vilahur, Professor J. ten Berg, Doctor J. Ferreiro, Professor T. Geisler
Access
Video
Thumbnail

About the event

Image

Hot topics and new insights for Thrombosis 2022

17 March 2022 17:00 CET

Seminar
logo Image
Access

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb